) has announced the launch of a novel scientific search engine,
especially designed to offer research workers an easy access over
peer-reviewed articles and abstract information on the company's
The new search engine enables scientists to instantly read the
entire text of millions of peer-reviewed papers without any extra
clicks or logins and discover applications for specific
Sigma-Aldrich products in peer-reviewed literature. It is also
equipped to provide free access to the Ingenuity gene and
biological pathway database. This approach enhances the
scientific search process and aids the research community by
finding better information.
Pubget, a solutions provider which focuses on expediting the
acquisition and analysis of contents, extended its technology for
accessing instant full-text papers, products and technical data,
along with the methods and gene data in the search tool on the
Sigma-Aldrich website. This tool is handy as it allows scientists
to spend more time on doing research and save time on searching.
The Ingenuity Systems Platform powers the biological search on
the Sigma-Aldrich website by using the Target Explorer web
services. Target Explorer provides exclusive biological content
that is advanced, comprehensive and relevant to searches
conducted by scientists through the Sigma-Aldrich website.
Last month, Sigma-Aldrich posted its first-quarter 2013
adjusted earnings of $1.03 per share, above the year-ago earnings
of 99 cents. The results beat the Zacks Consensus Estimate of
$1.00. Profit, as reported, rose roughly 4.3% year over year to
$122 million (or $1.01 per share) in the quarter from $117
million (or 96 cents per share) a year ago.
Revenues rose 1.5% year over year to $675 million in the
quarter, matching the Zacks Consensus Estimate. Acquisitions
added 2% to sales while foreign exchange translation had a
negative impact of 1%. Sigma-Aldrich's overall end markets
remained steady with improving pharma trends.
Sigma-Aldrich currently maintains a Zacks Rank #4 (Sell).
Other companies in the specialty chemical space with favorable
Zacks Rank are
American Pacific Corporation
American Vanguard Corp
). While American Pacific and American Vanguard hold a Zacks Rank
#1 (Strong Buy), Ferro Corp retains a Zacks Rank #2 (Buy).
AMER PAC CORP (APFC): Get Free Report
AMER VANGUARD (AVD): Free Stock Analysis
FERRO CORP (FOE): Free Stock Analysis Report
SIGMA ALDRICH (SIAL): Free Stock Analysis
To read this article on Zacks.com click here.